HIGH DOSE CHEMOTHERAPY WITH ALLOGENEIC OR AUTOLOGOUS STEM CELL and/or PROGENITOR CELL SUPPORT

High dose chemotherapy (HDC) with allogeneic or autologous stem and/or progenitor cell support is not covered for any disease or condition other than those that are addressed through specific policy. Specific coverage policies are listed individually.

Coverage of high dose chemotherapy with allogeneic or autologous stem and/or progenitor cell support for a patient with two active malignant diseases is covered only if both diseases have a specific coverage policy and the patient meets all criteria for both high dose chemotherapy with stem and/or progenitor cell treatment regimens.

View Policy